Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R D Christen

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Cancer Research|November 1, 1996
The role of DNA mismatch repair in platinum drug resistanceD Fink, S Nebel, S Aebi, et al.
British Journal of Cancer|January 1, 1993
Regulation of initial vinblastine influx by P-glycoproteinD R Shalinsky, A P Jekunen, J E Alcaraz, et al.
The Journal of Clinical Investigation|November 1, 1990
Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatinR D Christen, D K Hom, D C Porter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
all-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cellsS Aebi, R Kröning, B Cenni, et al.
British Journal of Cancer|June 9, 1999
Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatinB Cenni, H K Kim, G J Bubley, et al.
Investigational New Drugs|December 16, 1998
Phase I and pharmacokinetic study of intraperitoneal topotecanS C Plaxe, R D Christen, J O'Quigley, et al.
Cancer|March 1, 1997
A phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanomaE F McClay, M E McClay, J A Jones, et al.
Cancer Research|August 1, 1997
Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatinA Nehmé, R Baskaran, S Aebi, et al.
British Journal of Cancer|September 1, 1995
Enhancement of drug sensitivity of human malignancies by epidermal growth factorR Kröning, J A Jones, D K Hom, et al.
Cancer|September 15, 1993
Tamoxifen modulation of cisplatin resistance in patients with metastatic melanoma. A biologically important observationE F Mc Clay, M E Mc Clay, K D Albright, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Cancer Research|November 1, 1996
The role of DNA mismatch repair in platinum drug resistanceD Fink, S Nebel, S Aebi, et al.
British Journal of Cancer|January 1, 1993
Regulation of initial vinblastine influx by P-glycoproteinD R Shalinsky, A P Jekunen, J E Alcaraz, et al.
The Journal of Clinical Investigation|November 1, 1990
Epidermal growth factor regulates the in vitro sensitivity of human ovarian carcinoma cells to cisplatinR D Christen, D K Hom, D C Porter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
all-trans retinoic acid enhances cisplatin-induced apoptosis in human ovarian adenocarcinoma and in squamous head and neck cancer cellsS Aebi, R Kröning, B Cenni, et al.
British Journal of Cancer|June 9, 1999
Loss of DNA mismatch repair facilitates reactivation of a reporter plasmid damaged by cisplatinB Cenni, H K Kim, G J Bubley, et al.
Investigational New Drugs|December 16, 1998
Phase I and pharmacokinetic study of intraperitoneal topotecanS C Plaxe, R D Christen, J O'Quigley, et al.
Cancer|March 1, 1997
A phase I and pharmacokinetic study of high dose tamoxifen and weekly cisplatin in patients with metastatic melanomaE F McClay, M E McClay, J A Jones, et al.
Cancer Research|August 1, 1997
Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatinA Nehmé, R Baskaran, S Aebi, et al.
British Journal of Cancer|September 1, 1995
Enhancement of drug sensitivity of human malignancies by epidermal growth factorR Kröning, J A Jones, D K Hom, et al.
Cancer|September 15, 1993
Tamoxifen modulation of cisplatin resistance in patients with metastatic melanoma. A biologically important observationE F Mc Clay, M E Mc Clay, K D Albright, et al.
Pageof 4